ArticleNature communications2025

Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy.

Zhixiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.